Overview

Metabolic profiling — also known as untargeted metabolomics — is the comprehensive measurement of small-molecule metabolites in a biological sample. Metabolites are the end products of cellular processes and their levels reflect the integrated response of the genome, transcriptome, and proteome to genetic and environmental perturbations. Unlike targeted approaches that quantify a predefined set of compounds, metabolic profiling aims to detect as many metabolites as possible simultaneously, generating a global snapshot of the metabolome. This holistic view can reveal unexpected metabolic changes and generate novel hypotheses about disease mechanisms, drug action, and physiological regulation.

Key Concepts

Analytical platforms for metabolic profiling are dominated by mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy, each with complementary strengths. MS offers higher sensitivity and broader coverage, while NMR provides exceptional reproducibility and non-destructive quantification. Data preprocessing includes peak detection, alignment, normalization, and filtering to correct for batch effects and instrumental drift. Multivariate statistical analysis — principal component analysis (PCA), partial least-squares discriminant analysis (PLS-DA), and random forests — is used to identify metabolites that discriminate between experimental groups. Metabolite identification remains the major bottleneck, requiring accurate mass, retention time, and fragmentation spectra matched against reference libraries.

Applications

Metabolic profiling is applied across biomarker discovery, toxicology, functional genomics, and nutritional science. It identifies metabolic signatures of diseases such as cancer, diabetes, and inborn errors of metabolism. The approach bridges metabolic pathways with real-time physiological states, leverages mass spectrometry for broad coverage, and benefits from NMR spectroscopy for robust quantification of abundant metabolites.